...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >FABRICATION AND IN VITRO EVALUATION OF NATEGLINIDE-LOADED ETHYL CELLULOSE NANOPARTICLES
【24h】

FABRICATION AND IN VITRO EVALUATION OF NATEGLINIDE-LOADED ETHYL CELLULOSE NANOPARTICLES

机译:萘乙酸负载的乙基纤维素纳米颗粒的制备及体外评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: The objective of the present study is to formulate freeze-dried oral sustained release polymeric nanoparticles of nateglinide (NTG) to decrease dosing frequency, increase bioavailability, and minimize side effects. Methods: NTG-loaded ethyl cellulose (EC) nanoparticles were prepared by solvent evaporation technique and subjected to various studies for characterization, such as particle size, zeta potential, drug loading (DL), entrapment efficiency (EE), scanning electron microscopy, and evaluated for in vitro drug release. Results: From this study, it was observed that the fabricated nanoparticles showed satisfactory results, i.e. particle size with 172 nm, 72.19% EE, ?15.81 mV zeta potential, and 14.30% DL. The results of in vitro release show that sustained release of NTG from the nanoparticles over the period of 12 hrs and comparable with the immediate release tablets. Furthermore, accelerated stability studies revealed that the formulation is stable as per International Conference on Harmonisation guidelines. Conclusion: Thus, the nanoparticles formulation could be a promising delivery system for NTG with improved anti-diabetic activity, stability, and bioavailability.
机译:目的:本研究的目的是配制那格列奈(NTG)的冻干口服缓释聚合物纳米颗粒,以降低给药频率,增加生物利用度并将副作用减至最小。方法:采用溶剂蒸发技术制备了负载有NTG的乙基纤维素(EC)纳米颗粒,并对其进行了表征,粒度,ζ电位,载药量(DL),包封率(EE),扫描电子显微镜和评估体外药物释放。结果:从该研究中,观察到制备的纳米颗粒显示出令人满意的结果,即具有172nm,72.19%EE,〜15.81mV zeta电势和14.30%DL的粒径。体外释放的结果表明,NTG在12小时内从纳米颗粒持续释放,与速释片相当。此外,加速稳定性研究表明,根据国际协调会议指南,该制剂是稳定的。结论:因此,纳米颗粒制剂可作为具有改善的抗糖尿病活性,稳定性和生物利用度的NTG的有希望的递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号